Another report also revealed that SMCA1 overexpression may be an adverse factor for prognosis in advanced CRC, and SMC1A knockdown inhibited the cell proliferation and cell cycle processes of CRC by blocking the activation of AKT and MAP kinases.17 Here, AKT1 is linked to colorectal carcinoma.